These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current view on the perspectives of interferon therapy. Borecký L Acta Virol; 1986 Mar; 30(2):161-9. PubMed ID: 2425613 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the study of interferon. Ho M Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986 [No Abstract] [Full Text] [Related]
4. [Perspectives on interferon research and on its therapeutic use]. Montagnier L Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080 [TBL] [Abstract][Full Text] [Related]
5. [The interferon system with special reference to gamma-interferons]. Kirchner H Dtsch Med Wochenschr; 1986 Jan; 111(2):64-70. PubMed ID: 2416525 [No Abstract] [Full Text] [Related]
6. [Experimental research to clinical application of interferons]. Imamishi J; Tanaka A Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966 [TBL] [Abstract][Full Text] [Related]
8. The interferons--Part 1. Freeman PR Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644 [No Abstract] [Full Text] [Related]
9. [The interferon system. A review of biological principles and clinical uses]. Schneider FJ Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387 [TBL] [Abstract][Full Text] [Related]
10. [Antiviral effects of interferons and their inducers in experimental animals (author's transl)]. Suzuki F; Saito N; Ishida N Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):260-70. PubMed ID: 796876 [No Abstract] [Full Text] [Related]
11. [Interferon--the prospects and problems of its use in therapeutic and oncological practice]. Poverennyĭ AM Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171 [No Abstract] [Full Text] [Related]
12. [The medical significance of interferons and their inducers]. Ershov FI Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201 [TBL] [Abstract][Full Text] [Related]
13. Clinical testing of human interferon in infectious diseases. Merigan TC In Vitro Monogr; 1974; (3):57-62. PubMed ID: 4377883 [No Abstract] [Full Text] [Related]
14. [Interferon as an antiviral, antineoplastic and immunomodulating agent]. Inglot AD Postepy Hig Med Dosw; 1980; 34(2):89-105. PubMed ID: 6165980 [No Abstract] [Full Text] [Related]
15. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Pollard RB Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188 [No Abstract] [Full Text] [Related]
16. [Interferons. Structure, functions and therapeutic applications of interferons]. Marcellin P Ann Med Interne (Paris); 1993; 144(8):539-47. PubMed ID: 7513979 [No Abstract] [Full Text] [Related]
17. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
19. [Clinical use of interferon and its inducers]. Nosik NN; Ershov FI Antibiotiki; 1980 Sep; 25(9):695-710. PubMed ID: 6158289 [No Abstract] [Full Text] [Related]
20. Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Preble OT; Friedman RM Lab Invest; 1983 Jul; 49(1):4-18. PubMed ID: 6191121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]